Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 6/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.49 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.49 |
| ▸ | TTR | P02766 | 1/20 | 0.43 |
| ▸ | SNCA | P37840 | 2/20 | 0.40 |
| ▸ | CHAT | P28329 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | COMT | P21964 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30203973 | 1.00 | TYMS (0.54) | TYMSAURKAAURKBTTRSNCA | |
| SCHEMBL3828946 | 0.87 | AURKA (0.53) | TYMSAURKAAURKBTTRSNCA | |
| SCHEMBL15851430 | 0.84 | AURKA (0.53) | AURKAAURKBTTRSNCACHAT | |
| SCHEMBL9479925 | 0.83 | TYMS (0.59) | TYMSALOX15TDP1CYP1A2MEN1 | |
| SCHEMBL6391678 | 0.82 | TYMS (0.42) | TYMSAURKAAURKBTTRSNCA | |
| SCHEMBL8291788 | 0.81 | POLB (0.56) | AURKAAURKBALOX15TDP1CYP1A2 | |
| Potassium Ion SCHEMBL3736126 | 0.81 | TYMS (0.53) | TYMSALOX15TDP1CYP1A2MEN1 | |
| Potassium Ion SCHEMBL30617892 | 0.81 | TYMS (0.53) | TYMSALOX15TDP1CYP1A2MEN1 | |
| SCHEMBL6389483 | 0.81 | TIMP3 (0.39) | TYMSAURKAAURKBTTRTDP1 | |
| SCHEMBL11769544 | 0.80 | TYMS (0.44) | TYMSAURKAAURKBTTRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116836116-A | Novel PLK1 inhibitor and preparation method and application thereof | 广西师范大学 | 2023-10-03 | — | — | CN | claimed |
| CN-115064385-A | Manufacturing method of chip capacitor, polymerization solution and polymerization method | 肇庆绿宝石电子科技股份有限公司 | 2022-09-16 | — | — | CN | claimed |
| CN-114864304-A | Capacitor preparation process capable of reducing leakage current and capacitor | 肇庆绿宝石电子科技股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-114694973-A | Method for preparing conducting polymer by ultrasonic wave and solid capacitor | 肇庆绿宝石电子科技股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114664567-A | Preparation method of chip capacitor unit with extremely low ESR | 肇庆绿宝石电子科技股份有限公司 | 2022-06-24 | — | — | CN | claimed |
| CN-114664568-A | Method for reducing equivalent series resistance of laminated capacitor | 肇庆绿宝石电子科技股份有限公司 | 2022-06-24 | — | — | CN | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| JP-2007536237-A | — | — | 2007-12-13 | — | — | JP | claimed |
| US-20070148124-A1 | Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases | NOVAFLUX INC. | 2007-06-28 | — | — | US | claimed |
| EP-1749041-A2 | CELLULOSE AND ACRYLIC BASED POLYMERS AND THE USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES | Nova Flux Biosciences, Inc. (US) | 2007-02-07 | — | — | EP | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| WO-2005111112-A2 | CELLULOSE AND ACRYLIC BASED POLYMERS AND THE USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES | NOVA FLUX BIOSCIENCES, INC. (US) | 2005-11-24 | — | — | WO | claimed |
| US-20040242838-A1 | Sulfonated polyester and process therewith | DUAN JIWEN F (US) | 2004-12-02 | — | — | US | claimed |
| JP-5222028-A | — | — | None | — | — | JP | disclosed |
| US-4143020-A | COPOLYMERS OF SULFONIC ACID MONOMERS | ROHM AND HAAS COMPANY (US) | 1979-03-06 | — | — | US | disclosed |
| US-4131736-A | Polymers of sulfonic acid monomers | ROHM AND HAAS COMPANY (US) | 1978-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | TYMS 4322/4885AURKA 1397/4885AURKB 1294/4885 |
| US-20070148124-A1 | Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases | ALG1, CHIT1, CHIA | TYMS 1838/4885AURKA 1882/4885AURKB 3127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.